SELLAS Life Sciences (SLS) Amortizatization of Intangibles (2016 - 2026)
SELLAS Life Sciences (SLS) posted quarterly Amortizatization of Intangibles of $1000.0 for Q4 2017, down 96.3% quarter-over-quarter from $27000.0 in Q3 2017.
Powered by 
Analysis
SELLAS Life Sciences (SLS) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Amortizatization of Intangibles for 2 consecutive years, with $1000.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Amortizatization of Intangibles changed N/A year-over-year to $1000.0; the TTM figure through Dec 2017 stood at $258000.0 (changed N/A YoY), while the FY2017 annual figure was $258000.0, changed N/A from the prior year.
- Amortizatization of Intangibles slipped to $1000.0 in Q4 2017 per SLS's latest filing, from $27000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $650000.0 in Q1 2017 and bottomed at -$420000.0 in Q2 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 678,000.00 |
| 10 | SELLAS Life Sciences | 2.65 Bn | 2.65 Bn | - | 154,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154,000.00 |
| Mar 31, 2026 | 153,000.00 |
| Dec 31, 2025 | 154,000.00 |
| Sep 30, 2025 | 147,000.00 |
| Jun 30, 2025 | 149,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 138,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Dec 31, 2023 | 128,000.00 |
| Sep 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 158,000.00 |
| Mar 31, 2023 | 87,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | 207,000.00 |
| Jun 30, 2022 | 82,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Sep 30, 2017 | 27,000.00 |